Patents by Inventor Karen J. Moore

Karen J. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOTOR ASSIST ANALYTIC SYSTEM FOR AN ELECTRIC BICYCLE
    Publication number: 20230384106
    Abstract: A portable electronic device configured to be used by a user riding an electric bicycle (eBike). The portable electronic device is configured to connect in data communication with the eBike; receive an indication of a selected route over which the user intends to ride the eBike; determine, from map data and user data, an anticipated amount of motor assistance to be provided by the electric motor during the user's ride over the selected route; obtain an indication of a charge level of the battery of the eBike; determine, based on the anticipated amount of motor assistance and the charge level of the battery, whether the charge level of the battery of the eBike is sufficient to complete the user's ride over the selected route; and present an indication of whether the charge level of the battery of the eBike is sufficient to complete the user's ride over the selected route.
    Type: Application
    Filed: May 26, 2023
    Publication date: November 30, 2023
    Inventors: Sarah E. Fanning, Jordan K. Cowen, Karen J. Moore
  • Screening methods for compounds useful for the treatment of body weight disorders, including obesity
    Patent number: 6605437
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: August 12, 2003
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Compositions for the diagnosis and treatment of chediak-higashi syndrome
    Publication number: 20020115144
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible for the human Chediak-Higashi syndrome.
    Type: Application
    Filed: August 10, 2001
    Publication date: August 22, 2002
    Applicant: Millennium
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore
  • Screening methods for compounds useful for the treatment of body weight disorders, including obesity
    Publication number: 20020068286
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Application
    Filed: March 22, 2001
    Publication date: June 6, 2002
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • RP compositions and therapeutic and diagnostic uses therefor
    Patent number: 6399760
    Abstract: The present invention, which is based on the discovery of novel genes encoding rp polypeptides, features therapeutics, diagnostics and screening assays.
    Type: Grant
    Filed: August 29, 1996
    Date of Patent: June 4, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Carlos J. Gimeno, Patrick W. Kleyn, Karen J. Moore
  • Compositions for the diagnosis and treatment of Chediak-Higashi syndrome
    Patent number: 6310182
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible or the human Chediak-Higashi syndrome.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: October 30, 2001
    Assignees: Millennium Pharmaceuticals, Inc., The University of Utah Research Foundation
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore
  • RP compositions and diagnostic uses therefor
    Patent number: 6268130
    Abstract: The invention provides isolated nucleic acids molecules, designated retinitis pigmentosa (“rp”) nucleic acid molecules, which encode polypeptides involved in the regulation of sensory functions, e.g., retinal functions, e.g., functions of the rod and cone photoreceptor cells of the retina, body weight, and/or metabolic functions. The invention also provides antisense nucleic acid molecules, expression vectors containing rp nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an rp gene has been introduced or disrupted. The invention still further provides isolated rp polypeptides, fusion proteins, antigenic peptides, and anti-rp antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: July 31, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Compositions for the treatment and diagnosis of body weight disorders, including obesity
    Patent number: 6207386
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: March 27, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Compositions for the treatment and diagnosis of body weight disorders, including obesity
    Patent number: 6043346
    Abstract: The present invention relates to antibodies which specifically bind to mammalian tub gene products, tub peptide fragments and tub peptides produced by genetically engineered cells.
    Type: Grant
    Filed: February 10, 1999
    Date of Patent: March 28, 2000
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Compositions for the diagnosis and treatment of Chediak-Higashi syndrome
    Patent number: 5952223
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the differentiation and/or function of intracellular vesicles. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian bg gene, a gene that, when mutated, is responsible for the human Chediak-Higashi syndrome.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: September 14, 1999
    Assignees: Millennium Pharmaceuticals, The University of Utah Research Foundation
    Inventors: Jerry Kaplan, Charles M. Perou, Karen J. Moore
  • Methods for identifying compounds that bind to a mammalian tub protein
    Patent number: 5876919
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: March 2, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Methods for detecting mammalian tub protein and RNA
    Patent number: 5871931
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: February 16, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Methods for identifying compounds that modulate mammalian tub protein activity
    Patent number: 5861239
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the gene corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight. The present invention also relates to methods for identifying compounds that modulate tub protein activity.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: January 19, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore, Rosana Kapeller
  • Mammalian tub protein
    Patent number: 5817762
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: October 6, 1998
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore
  • Mammalian tub gene
    Patent number: 5646040
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: July 8, 1997
    Assignee: Millennium Pharmaceutical, Inc.
    Inventors: Patrick W. Kleyn, Karen J. Moore